Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | BG-68501 |
Synonyms | |
Therapy Description |
Limited information is currently available on BG-68501, a putative CDK2 inhibitor (Mar 2024). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
BG-68501 | BG 68501|BG68501 | CDK2 Inhibitor 31 | Limited information is currently available on BG-68501, a putative CDK2 inhibitor (Mar 2024). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT06257264 | Phase I | BG-68501 + Fulvestrant BG-68501 | A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors | Recruiting | USA | AUS | 1 |